Smart TMS
- Date of Transaction: Jul 2024
- Acquirer: neurocare AG
- Service: M&A
- Sector: Healthcare
"It was a pleasure to work with Gordon and Sam, and we are delighted to have found such a good home in neurocare" Gerard Barnes, CEO Smart TMS
Personalized mental health care company neurocare group AG announces acquisition of Smart TMS clinics in the UK
Founded in 2015, Smart TMS was among the first to introduce the neuromodulation technique into patient care in the United Kingdom and offer TMS for the treatment of OCD (obsessive compulsive disorder), addiction, and adolescent psychiatry. Smart TMS currently runs nine clinics across the UK and Ireland. With several reimbursement agreements with private health insurance companies already in place, Smart TMS is a trusted provider for health insurance companies across the UK, offering care for patients with major depression.
Neurocare Group is a German healthcare company specializing in innovative mental health solutions. Their core focus is on empowering clinicians to deliver personalized and effective treatment plans. Through their digital therapy platform, they provide tools and resources to optimize clinical workflows and patient care. Additionally, Neurocare operates its own network of clinics offering advanced treatments for conditions like depression and ADHD. By combining technology, clinical expertise, and patient-centric care, Neurocare aims to improve mental health outcomes and enhance overall well-being.
This acquisition marks a significant expansion of neurocare's clinic network. It broadens access to the Company’s holistic approach to mental health care, including innovative therapies and tools including innovative therapies and neuromodulation tools such as TMS to help clinicians deliver personalized treatments with sustainable clinical outcomes for patients.
Gerard Barnes, Founder and Chief Executive of Smart TMS says: “We look forward to joining forces with neurocare to expand and improve deliverability of TMS and other innovative mental health treatments across the UK. Our team will benefit from sharing expertise with a global network, as well as having access to resources and tools to serve more patients effectively.”
Dr Gordon Hamilton, Managing Director, said “We are delighted to have advised Gerard on this important transaction that will expand Smart TMS’s range of services available to its patients. In neurocare group, Smart TMS has found a strong strategic partner to continue the expansion of the business“
Welcome to Alpha Helix
We are pleased to announce that on 12th March of this year, Gordon Hamilton led the MBO of Nexus Corporate Finance (NCF), therefore we have re-branded as Alpha Helix Corporate Finance (AHCF).
The team will remain unchanged and will continue to provide independent advice to exciting and fast-growing UK SMEs in the Healthcare sector.